{{Rsnum
|rsid=3781838
|Gene=SORL1
|Chromosome=11
|position=121582808
|Orientation=plus
|GMAF=0.05142
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=SORL1
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 0.0 | 3.1 | 96.9
| HCB | 0.0 | 8.9 | 91.1
| JPT | 2.3 | 29.5 | 68.2
| YRI | 0.0 | 11.3 | 88.7
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 8.9 | 91.1
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs3781838
|Name_s=
|Gene_s=SORL1
|Feature=
|Evidence=PubMed ID:17553421; PubMed ID:19118814
|Annotation=This variant is nominally associated with late-onset Alzheimer disease (LOAD) in 2 GWAS studies.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363861
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3781838
|overall_frequency_n=9
|overall_frequency_d=128
|overall_frequency=0.0703125
|n_genomes=9
|n_genomes_annotated=0
|n_haplomes=9
|n_articles=0
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=2
|webscore=N
|n_web_uneval=5
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}